Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Understanding why some breast cancer patients feel swelling without measurable lymphedema

Official title: The Enigma of Subjective Lymphedema: Who and Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable Swelling? The Role of Lymphatic and Sensory Processing Problems

Run by Universitaire Ziekenhuizen KU Leuven · NCT06324721 · Data updated 2026-11-12

This study is trying to understand why some breast cancer patients feel swelling in their arms or chest even when tests show they don't have lymphedema, to help improve their care.

More Breast Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment230 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations1 site (Leuven, Vlaams-Brabant)
StatusRecruiting
StartedMarch 26, 2024
Main results expectedMay 2027
Study endsMay 2027
Registry record updatedJanuary 29, 2025
Trial IDNCT06324721 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with unilateral non-metastatic or oligometastatic breast cancer who are scheduled for surgery.

Probably not a fit

Patients with distant metastases, planned bilateral lymph node surgery, or edema from other causes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the phenomenon of subjective breast cancer-related lymphedema (BCRL), where patients report sensations of swelling despite no objective evidence of lymphedema. It aims to explore the prevalence and transitions between different states of BCRL over time, as well as the underlying mechanisms contributing to these sensations. Various measurement techniques will be employed, including volumetric measurements, bioimpedance spectroscopy, and sensory processing assessments. The goal is to better understand the factors influencing subjective BCRL to improve patient care.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies for patients experiencing subjective sensations of swelling after breast cancer treatment.

How similar studies have gone: While the specific focus on subjective BCRL is novel, related studies on lymphedema have shown varying degrees of success in understanding and managing the condition.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. adults (men and women) who are ≥ 18 years of age
2. diagnosed with primary unilateral non-metastatic or oligometastatic breast cancer
3. scheduled for surgery (mastectomy or breast conserving surgery; in combination with axillary lymph node dissection or sentinel node biopsy)
4. able to read, understand, and speak Dutch
5. have voluntary written informed consent of the patient

Exclusion Criteria:

1. distant metastases
2. planned bilateral lymph node surgery
3. oedema of the arm from another cause
4. an allergy to iodine or Indocyanine Green (ICG), or
5. physically or mentally unable to participate throughout the entire duration of the study

Where it's running

  • University Hospitals of Leuven, center for lymphedema
    Leuven, Vlaams-Brabant, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Comparing two nerve-block options to reduce pain after total mastectomy.

    This test tries whether a PECS-II block given before surgery or a pectoral block given during surgery, using bupivacaine or liposomal bupivacaine, provides better pain control after total mastectomy for breast cancer or high-risk patients.

    Recruiting Phase 4 University of Cincinnati · Cincinnati, Ohio · NCT06574022

  • Developing a treatment protocol for chronic lymphedema after breast cancer surgery

    This study is trying to create a clear treatment plan for managing chronic lymphedema after breast cancer surgery to help improve patients' lives and make it easier for them to get insurance coverage for the care they need.

    Recruiting University Hospital, Basel, Switzerland · Basel · NCT06374745

  • Program to prevent lymphedema after breast cancer surgery

    This study is testing a prevention program to help women who have breast cancer surgery avoid lymphedema by using treatments like lymphatic massage and special garments.

    Recruiting at 7 sites Phase 3 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06144164

  • Upfront treatment for breast cancer with nodal metastases

    This study is testing if starting treatment with surgery and targeted therapy can help women with early-stage breast cancer that has spread to their lymph nodes live longer and have fewer recurrences.

    Recruiting at 3 sites Phase 2 Cedars-Sinai Medical Center · Los Angeles, California and 2 other locations · NCT06092892

  • Screening for Breast Cancer-Related Lymphedema in Targeted Therapy

    This study tests whether targeted breast cancer therapies are linked to lymphedema by tracking arm volume and symptoms in women undergoing treatment.

    Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT05142800

  • Preventing lymphedema after breast cancer surgery

    This study is testing a new procedure to see if connecting lymph vessels can help prevent swelling in the arm for women having surgery for breast cancer.

    Recruiting Gangnam Severance Hospital · Seoul · NCT04687956

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.